Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet

Fig. 2

Effect of saroglitazar on liver histology (H&E staining). Representative images of liver sections stained with hematoxylin-eosin and observed at 20X resolution and scale bar 40 μm. Liver sections of animals fed a normal control diet appeared to be normal. Hepatocellular adenoma (Red arrow) and zone of compression (yellow arrow) were observed in disease control, which was completely reversed in animals treated with 3 mg/kg saroglitazar

Back to article page